APO Research
Talk to an analyst

APO RESEARCH · REPORT

AI Medical Imaging Software for Cardiovascular Disease

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global AI Medical Imaging Software for Cardiovascular Disease Market Outlook and Growth Opportunities 2026

5 June 2026196 pages

Choose your research edition.

Industry ResearchAI Medical Imaging Software for Cardiovascular Disease Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal AI Medical Imaging Software for Cardiovascular Disease Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal AI Medical Imaging Software for Cardiovascular Disease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AI Medical Imaging Software for Cardiovascular Disease Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal AI Medical Imaging Software for Cardiovascular Disease Market Analysis and Forecast 2026-2032227 pages · $4,950 USD

Market perspective

The global AI Medical Imaging Software for Cardiovascular Disease market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for AI Medical Imaging Software for Cardiovascular Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AI Medical Imaging Software for Cardiovascular Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AI Medical Imaging Software for Cardiovascular Disease is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the AI Medical Imaging Software for Cardiovascular Disease market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the AI Medical Imaging Software for Cardiovascular Disease market include Siemens, United-Imaging, Deepwise, Atrui Technology, Lepu Medical, Keya Medical, RaysightMed, Shukun Technology and Infervision Medical, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global AI Medical Imaging Software for Cardiovascular Disease market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AI Medical Imaging Software for Cardiovascular Disease and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AI Medical Imaging Software for Cardiovascular Disease revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global AI Medical Imaging Software for Cardiovascular Disease market.

AI Medical Imaging Software for Cardiovascular Disease Segment by Company

Siemens

United-Imaging

Deepwise

Atrui Technology

Lepu Medical

Keya Medical

RaysightMed

Shukun Technology

Infervision Medical

Yizhun Intelligent

Pulse Medical

Fosun Aitrox

Edan Instruments

Thoth Medical

Nalong Health

AI Medical Imaging Software for Cardiovascular Disease Segment by Type

Cloud-Based

On-Premise

AI Medical Imaging Software for Cardiovascular Disease Segment by Application

Hospital

Clinic

AI Medical Imaging Software for Cardiovascular Disease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global AI Medical Imaging Software for Cardiovascular Disease status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the AI Medical Imaging Software for Cardiovascular Disease key companies, revenue, market share, and recent developments.

3. To split the AI Medical Imaging Software for Cardiovascular Disease breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions AI Medical Imaging Software for Cardiovascular Disease market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify AI Medical Imaging Software for Cardiovascular Disease significant trends, drivers, influence factors in global and regions.

6. To analyze AI Medical Imaging Software for Cardiovascular Disease competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI Medical Imaging Software for Cardiovascular Disease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AI Medical Imaging Software for Cardiovascular Disease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI Medical Imaging Software for Cardiovascular Disease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AI Medical Imaging Software for Cardiovascular Disease industry.

Chapter 3: Detailed analysis of AI Medical Imaging Software for Cardiovascular Disease company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of AI Medical Imaging Software for Cardiovascular Disease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of AI Medical Imaging Software for Cardiovascular Disease in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. AI Medical Imaging Software for Cardiovascular Disease Industry Trends Table 2. AI Medical Imaging Software for Cardiovascular Disease Industry Drivers Table 3. AI Medical Imaging Software for Cardiovascular Disease Industry Opportunities and Challenges Table 4. AI Medical Imaging Software for Cardiovascular Disease Industry Restraints Table 5. Global AI Medical Imaging Software for Cardiovascular Disease Revenue by Company (US$ Million) & (2021-2026) Table 6. Global AI Medical Imaging Software for Cardiovascular Disease Revenue Share by Company (2021-2026) Table 7. Global AI Medical Imaging Software for Cardiovascular Disease Company Ranking, (2024-2026) & (US$ Million) Table 8. Global AI Medical Imaging Software for Cardiovascular Disease Key Company Manufacturing Base & Headquarters Table 9. Global AI Medical Imaging Software for Cardiovascular Disease Company, Product Type & Application Table 10. Global AI Medical Imaging Software for Cardiovascular Disease Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global AI Medical Imaging Software for Cardiovascular Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cloud-Based Table 15. Significant Companies of On-Premise Table 16. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type (2021-2026) Table 20. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Table 22. Significant Companies of Clinic Table 23. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application (2021-2026) Table 27. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application (2027-2032) Table 28. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Region (2021-2026) Table 31. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Region (2027-2032) Table 33. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Market Share by Country (2021-2026) Table 36. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Market Share by Country (2027-2032) Table 38. Siemens Company Information Table 39. Siemens Business Overview Table 40. Siemens AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Siemens AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 42. Siemens Recent Development Table 43. United-Imaging Company Information Table 44. United-Imaging Business Overview Table 45. United-Imaging AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. United-Imaging AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 47. United-Imaging Recent Development Table 48. Deepwise Company Information Table 49. Deepwise Business Overview Table 50. Deepwise AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Deepwise AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 52. Deepwise Recent Development Table 53. Atrui Technology Company Information Table 54. Atrui Technology Business Overview Table 55. Atrui Technology AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Atrui Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 57. Atrui Technology Recent Development Table 58. Lepu Medical Company Information Table 59. Lepu Medical Business Overview Table 60. Lepu Medical AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Lepu Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 62. Lepu Medical Recent Development Table 63. Keya Medical Company Information Table 64. Keya Medical Business Overview Table 65. Keya Medical AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Keya Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 67. Keya Medical Recent Development Table 68. RaysightMed Company Information Table 69. RaysightMed Business Overview Table 70. RaysightMed AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. RaysightMed AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 72. RaysightMed Recent Development Table 73. Shukun Technology Company Information Table 74. Shukun Technology Business Overview Table 75. Shukun Technology AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Shukun Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 77. Shukun Technology Recent Development Table 78. Infervision Medical Company Information Table 79. Infervision Medical Business Overview Table 80. Infervision Medical AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Infervision Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 82. Infervision Medical Recent Development Table 83. Yizhun Intelligent Company Information Table 84. Yizhun Intelligent Business Overview Table 85. Yizhun Intelligent AI Medical Imaging Software for Cardiovascular Disease Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Yizhun Intelligent AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 87. Yizhun Intelligent Recent Development Table 88. Pulse Medical Company Information Table 89. Pulse Medical Business Overview Table 90. Pulse Medical AI Medical Imaging Software for Cardiovascular Disease Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Pulse Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 92. Pulse Medical Recent Development Table 93. Fosun Aitrox Company Information Table 94. Fosun Aitrox Business Overview Table 95. Fosun Aitrox AI Medical Imaging Software for Cardiovascular Disease Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Fosun Aitrox AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 97. Fosun Aitrox Recent Development Table 98. Edan Instruments Company Information Table 99. Edan Instruments Business Overview Table 100. Edan Instruments AI Medical Imaging Software for Cardiovascular Disease Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Edan Instruments AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 102. Edan Instruments Recent Development Table 103. Thoth Medical Company Information Table 104. Thoth Medical Business Overview Table 105. Thoth Medical AI Medical Imaging Software for Cardiovascular Disease Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Thoth Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 107. Thoth Medical Recent Development Table 108. Nalong Health Company Information Table 109. Nalong Health Business Overview Table 110. Nalong Health AI Medical Imaging Software for Cardiovascular Disease Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Nalong Health AI Medical Imaging Software for Cardiovascular Disease Product Portfolio Table 112. Nalong Health Recent Development Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources Table 116. Primary Sources List of Figures Figure 1. AI Medical Imaging Software for Cardiovascular Disease Product Image Figure 2. Global AI Medical Imaging Software for Cardiovascular Disease Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032) & (US$ Million) Figure 4. Global AI Medical Imaging Software for Cardiovascular Disease Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cloud-Based Image Figure 8. On-Premise Image Figure 9. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type (2021-2032) Figure 12. Hospital Image Figure 13. Clinic Image Figure 14. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application (2021-2032) Figure 17. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032) & (US$ Million) Figure 20. North America AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032) & (US$ Million) Figure 22. Europe AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032) & (US$ Million) Figure 26. South America AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-Based
  • On-Premise
Applications
  • Hospital
  • Clinic
Companies covered
  • Siemens
  • United-Imaging
  • Deepwise
  • Atrui Technology
  • Lepu Medical
  • Keya Medical
  • RaysightMed
  • Shukun Technology
  • Infervision Medical
  • Yizhun Intelligent
  • Pulse Medical
  • Fosun Aitrox
  • Edan Instruments
  • Thoth Medical
  • Nalong Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global AI Medical Imaging Software for Cardiovascular Disease Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global AI Medical Imaging Software for Cardiovascular Disease Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 AI Medical Imaging Software for Cardiovascular Disease Market Dynamics
  1. 2.1 AI Medical Imaging Software for Cardiovascular Disease Industry Trends
  2. 2.2 AI Medical Imaging Software for Cardiovascular Disease Industry Drivers
  3. 2.3 AI Medical Imaging Software for Cardiovascular Disease Industry Opportunities and Challenges
  4. 2.4 AI Medical Imaging Software for Cardiovascular Disease Industry Restraints
3 AI Medical Imaging Software for Cardiovascular Disease Market by Company
  1. 3.1 Global AI Medical Imaging Software for Cardiovascular Disease Company Revenue Ranking in 2025
  2. 3.2 Global AI Medical Imaging Software for Cardiovascular Disease Revenue by Company (2021-2026)
  3. 3.3 Global AI Medical Imaging Software for Cardiovascular Disease Company Ranking (2024-2026)
  4. 3.4 Global AI Medical Imaging Software for Cardiovascular Disease Company Manufacturing Base and Headquarters
  5. 3.5 Global AI Medical Imaging Software for Cardiovascular Disease Company Product Type and Application
  6. 3.6 Global AI Medical Imaging Software for Cardiovascular Disease Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global AI Medical Imaging Software for Cardiovascular Disease Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 AI Medical Imaging Software for Cardiovascular Disease Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 AI Medical Imaging Software for Cardiovascular Disease Market by Type
  1. 4.1 AI Medical Imaging Software for Cardiovascular Disease Type Introduction
  2. 4.1.1 Cloud-Based
  3. 4.1.2 On-Premise
  4. 4.2 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Type
  5. 4.2.1 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Type (2021-2032)
  7. 4.2.3 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type (2021-2032)
5 AI Medical Imaging Software for Cardiovascular Disease Market by Application
  1. 5.1 AI Medical Imaging Software for Cardiovascular Disease Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Application
  5. 5.2.1 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Application (2021-2032)
  7. 5.2.3 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application (2021-2032)
6 AI Medical Imaging Software for Cardiovascular Disease Regional Value Analysis
  1. 6.1 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Region (2021-2032)
  3. 6.2.1 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Region: 2021-2026
  4. 6.2.2 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032)
  7. 6.3.2 North America AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032)
  10. 6.4.2 Europe AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032)
  16. 6.6.2 South America AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Country, 2025 VS 2032
7 AI Medical Imaging Software for Cardiovascular Disease Country-level Value Analysis
  1. 7.1 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Country (2021-2032)
  3. 7.2.1 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Country (2021-2026)
  4. 7.2.2 Global AI Medical Imaging Software for Cardiovascular Disease Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt AI Medical Imaging Software for Cardiovascular Disease Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt AI Medical Imaging Software for Cardiovascular Disease Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Siemens
  2. 8.1.1 Siemens Company Information
  3. 8.1.2 Siemens Business Overview
  4. 8.1.3 Siemens AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Siemens AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  6. 8.1.5 Siemens Recent Developments
  7. 8.2 United-Imaging
  8. 8.2.1 United-Imaging Company Information
  9. 8.2.2 United-Imaging Business Overview
  10. 8.2.3 United-Imaging AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  11. 8.2.4 United-Imaging AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  12. 8.2.5 United-Imaging Recent Developments
  13. 8.3 Deepwise
  14. 8.3.1 Deepwise Company Information
  15. 8.3.2 Deepwise Business Overview
  16. 8.3.3 Deepwise AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Deepwise AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  18. 8.3.5 Deepwise Recent Developments
  19. 8.4 Atrui Technology
  20. 8.4.1 Atrui Technology Company Information
  21. 8.4.2 Atrui Technology Business Overview
  22. 8.4.3 Atrui Technology AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Atrui Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  24. 8.4.5 Atrui Technology Recent Developments
  25. 8.5 Lepu Medical
  26. 8.5.1 Lepu Medical Company Information
  27. 8.5.2 Lepu Medical Business Overview
  28. 8.5.3 Lepu Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lepu Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  30. 8.5.5 Lepu Medical Recent Developments
  31. 8.6 Keya Medical
  32. 8.6.1 Keya Medical Company Information
  33. 8.6.2 Keya Medical Business Overview
  34. 8.6.3 Keya Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Keya Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  36. 8.6.5 Keya Medical Recent Developments
  37. 8.7 RaysightMed
  38. 8.7.1 RaysightMed Company Information
  39. 8.7.2 RaysightMed Business Overview
  40. 8.7.3 RaysightMed AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  41. 8.7.4 RaysightMed AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  42. 8.7.5 RaysightMed Recent Developments
  43. 8.8 Shukun Technology
  44. 8.8.1 Shukun Technology Company Information
  45. 8.8.2 Shukun Technology Business Overview
  46. 8.8.3 Shukun Technology AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shukun Technology AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  48. 8.8.5 Shukun Technology Recent Developments
  49. 8.9 Infervision Medical
  50. 8.9.1 Infervision Medical Company Information
  51. 8.9.2 Infervision Medical Business Overview
  52. 8.9.3 Infervision Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Infervision Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  54. 8.9.5 Infervision Medical Recent Developments
  55. 8.10 Yizhun Intelligent
  56. 8.10.1 Yizhun Intelligent Company Information
  57. 8.10.2 Yizhun Intelligent Business Overview
  58. 8.10.3 Yizhun Intelligent AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Yizhun Intelligent AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  60. 8.10.5 Yizhun Intelligent Recent Developments
  61. 8.11 Pulse Medical
  62. 8.11.1 Pulse Medical Company Information
  63. 8.11.2 Pulse Medical Business Overview
  64. 8.11.3 Pulse Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Pulse Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  66. 8.11.5 Pulse Medical Recent Developments
  67. 8.12 Fosun Aitrox
  68. 8.12.1 Fosun Aitrox Company Information
  69. 8.12.2 Fosun Aitrox Business Overview
  70. 8.12.3 Fosun Aitrox AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Fosun Aitrox AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  72. 8.12.5 Fosun Aitrox Recent Developments
  73. 8.13 Edan Instruments
  74. 8.13.1 Edan Instruments Company Information
  75. 8.13.2 Edan Instruments Business Overview
  76. 8.13.3 Edan Instruments AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Edan Instruments AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  78. 8.13.5 Edan Instruments Recent Developments
  79. 8.14 Thoth Medical
  80. 8.14.1 Thoth Medical Company Information
  81. 8.14.2 Thoth Medical Business Overview
  82. 8.14.3 Thoth Medical AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Thoth Medical AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  84. 8.14.5 Thoth Medical Recent Developments
  85. 8.15 Nalong Health
  86. 8.15.1 Nalong Health Company Information
  87. 8.15.2 Nalong Health Business Overview
  88. 8.15.3 Nalong Health AI Medical Imaging Software for Cardiovascular Disease Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Nalong Health AI Medical Imaging Software for Cardiovascular Disease Product Portfolio
  90. 8.15.5 Nalong Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst